Compare Alliant Energy Corporation (LNT) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alliant Energy Corporation vs Sanofi SA — how do they compare? Alliant Energy Corporation trades at $65.85 (market cap $16.99B), while Sanofi SA trades at $40.07 (market cap $95.18B). The key difference: Sanofi SA is far larger — about 5.6× Alliant Energy Corporation's market cap, and Sanofi SA pays the higher dividend (6.01%). Which is the better fit depends on your goals — on Pluang, investors hold Alliant Energy Corporation for 64 Days and Sanofi SA for 94 Days on average.
| LNT | SNY | |
|---|---|---|
Market Cap | $16.99B | $95.18B |
Volume | 2,488,387 | 2,995,646 |
Sector | Utilities | Health |
52-Week High | $78.03 | $52.34 |
52-Week Low | $63.21 | $39.51 |
Typical Hold Time | 64 Days | 94 Days |
Enterprise Value | $29.08B | $114.48B |
Dividend Yield | 3.27% | 6.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LNT trades at $65.50, up 0.44% today, with a bullish technical signal and support near $65. The company reported Q2 2026 EPS of $0.65, beating expectations, and maintains a strong net income margin of 18.45%. Recent news highlights a $1.4B partnership and institutional buying, while a $13.4B capital expenditure plan supports long-term growth.
Outlook is positive with a consensus price target of $77, implying 17.6% upside, driven by steady utility demand and data center growth. Risks include rising debt levels and cost pressures. Analysts are bullish with 52% buy ratings, but investors should monitor execution of the capex plan and interest rate impacts.
Sanofi (SNY) trades at $40.23, showing minimal daily movement with a 0.07% gain. The stock presents mixed signals with bearish technical indicators but strong fundamental performance, including three consecutive quarterly earnings beats. Recent expansion of the immunology alliance with Regeneron through an $8 billion deal highlights strategic growth initiatives. Valuation metrics show a P/E of 22.14 and P/S of 1.77, while profitability remains solid with a 72.77% gross margin.
SNY offers steady growth potential driven by pipeline expansion and Dupixent momentum, though patent expiration risks loom. Analyst sentiment is cautiously optimistic with 44% buy ratings, but technical weakness and projected 2026 earnings decline present near-term headwinds. The stock represents a balanced opportunity for long-term investors seeking pharmaceutical exposure with manageable risk.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
